Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...

Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD ® Centargo CT Injection System, an innovative multi-patient injector that drives workflow ...

WARRENDALE, Pa., Nov. 20 With the introduction of theSpectris Solaris(R) EP Mobile MR Injection System today, MEDRAD once againaddresses the challenges clinicians face in a mobile magnetic resonance ...

Bayer, a global enterprise with core competencies in the life science fields of health care and nutrition, announced 510(k) clearance from the US Food and Drug Administration (FDA) for its MEDRAD ...

Used in diagnostic imaging, MEDRAD ’ s product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment ...

Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...

Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...